CIK 0001766140 · <br>Emerging growth company
Unicycive Therapeutics, Inc.
Sign in to watch- Ticker
- UNCY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 813638692
- Phone
- 650-384-0642
- Business address
- 1975 W. EL CAMINO REAL, SUITE 204, MOUNTAIN VIEW, CA, 94040
- Former names
- Unicycive Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-28 | Manning Meredith Director | Grant or award · Restricted Stock Units | +3,350 | 3,350 | ||
| 2026-10-28 | Manning Meredith Director | Grant or award · Stock Options | +27,000 | 27,000 | ||
| 2026-05-14 | Kenkare-Mitra Sara Director | Grant or award · Restricted Stock Units | +47,941 | 47,941 | ||
| 2026-05-14 | Laumas Sandeep Director | Grant or award · Restricted Stock Units | +47,941 | 47,941 | ||
| 2026-05-14 | Gupta Shalabh K. CEO | Grant or award · Restricted Stock Units | +762,200 | 762,200 | ||
| 2026-05-14 | Kenkare-Mitra Sara Director | Grant or award · Restricted Stock Units | +84,200 | 84,200 | ||
| 2026-05-14 | Kenkare-Mitra Sara Director | Grant or award · Restricted Stock Units | +42,100 | 126,300 | ||
| 2026-05-14 | Laumas Sandeep Director | Grant or award · Restricted Stock Units | +84,200 | 84,200 | ||
| 2026-05-14 | Laumas Sandeep Director | Grant or award · Restricted Stock Units | +42,100 | 126,300 | ||
| 2026-05-14 | Gupta Pramod EVP, Pharmaceuticals and BD | Grant or award · Restricted Stock Unit | +169,500 | 169,500 | ||
| 2026-05-14 | Townsend John CFO | Grant or award · Restricted Stock Unit | +169,500 | 169,500 | ||
| 2026-05-14 | Jermasek Douglas EVP, Corporate Strategy | Grant or award · Restricted Stock Units | +169,500 | 169,500 | ||
| 2026-05-14 | Gupta Shalabh K. CEO | Grant or award · Restricted Stock Units | +762,200 | 762,200 | ||
| 2026-05-14 | Kenkare-Mitra Sara Director | Grant or award · Restricted Stock Units | +84,200 | 84,200 | ||
| 2026-05-14 | Kenkare-Mitra Sara Director | Grant or award · Restricted Stock Units | +42,100 | 126,300 | ||
| 2026-05-14 | Jermasek Douglas EVP, Corporate Strategy | Grant or award · Restricted Stock Units | +169,500 | 169,500 | ||
| 2026-05-14 | Townsend John CFO | Grant or award · Restricted Stock Unit | +169,500 | 169,500 | ||
| 2026-05-14 | Gupta Pramod EVP, Pharmaceuticals and BD | Grant or award · Restricted Stock Unit | +169,500 | 169,500 | ||
| 2026-05-14 | Laumas Sandeep Director | Grant or award · Restricted Stock Units | +84,200 | 84,200 | ||
| 2026-05-14 | Laumas Sandeep Director | Grant or award · Restricted Stock Units | +42,100 | 126,300 |
Page 1 of 5 · 84 trades